Lawrence B. Cohen’s Bristol-Myers Squibb BMY Stock Holding History

Lawrence B. Cohen’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-23,260	Closed	-$1.49M	–	61
2023 Q2	$1.49M	Sell	23,260 -9,913	-30%	-$665K	0.95%	44
2023 Q1	$2.3M	Buy	33,173 +1,184	+4%	+$83.5K	1.54%	29
2022 Q4	$2.3M	Buy	31,989 +2,836	+10%	+$214K	1.2%	32
2022 Q3	$2.07M	Buy	29,153 +11,706	+67%	+$849K	1.6%	20
2022 Q2	$1.34M	Buy	17,447 +7,606	+77%	+$579K	0.96%	45
2022 Q1	$719K	Buy	+9,841	New	+$661K	0.43%	49
2021 Q4	–	Sell	-4,052	Closed	-$240K	–	100
2021 Q3	$240K	Sell	4,052 -885	-18%	-$58.3K	0.13%	69
2021 Q2	$330K	Hold	4,937	–	–	0.17%	63
2021 Q1	$312K	Sell	4,937 -162	-3%	-$10.1K	0.17%	65
2020 Q4	$316K	Buy	5,099 +62	+1%	+$3.81K	0.18%	62
2020 Q3	$304K	Sell	5,037 -102	-2%	-$6.14K	0.18%	65
2020 Q2	$302K	Buy	5,139 +2	+0%	+$120	0.2%	63
2020 Q1	$286K	Buy	+5,137	New	+$314K	0.22%	64

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Lawrence B. Cohen's BMY Position: Q3 2023 in Review

Lawrence B. Cohen sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 23,260 shares — an estimated $1.49M sold.

Lawrence B. Cohen first reported a position in BMY in Q1 2020 and held it in 13 quarters. The position peaked at $2.3M in Q4 2022. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Lawrence B. Cohen reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
Lawrence B. Cohen sold 23,260 Bristol-Myers Squibb shares in Q3 2023, an estimated $1.49M.
Lawrence B. Cohen first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 13 quarters.
Lawrence B. Cohen's Bristol-Myers Squibb position peaked at $2.3M in Q4 2022.
2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Lawrence B. Cohen's 13F filing for Q3 2023, filed 23 Oct 2023.